CIK 0001048477
- Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680397820
- Phone
- +1 415-506-6700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-25 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −2,200 | 0 | ||
| 2023-01-25 | Ajer Jeffrey Robert EVP, Chief Commercial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −46,800 | 0 | ||
| 2023-01-17 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +10,000 | $67.81 | $678K | 330,424 |
| 2023-01-17 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −10,000 | $111.55 | $1.1M | 320,424 |
| 2023-01-17 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −10,000 | 193,130 | ||
| 2023-01-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion | +10,000 | $67.81 | $678K | 330,424 |
| 2023-01-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −10,000 | $112.25 | $1.1M | 320,424 |
| 2023-01-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −10,000 | 203,130 | ||
| 2023-01-13 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion | +2,500 | $63.10 | $158K | 30,246 |
| 2023-01-13 | Mueller Brian EVP, Chief Financial Officer | Sale | −2,500 | $114.50 | $286K | 27,746 |
| 2023-01-13 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −2,500 | 5,000 | ||
| 2022-12-13 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion | +2,500 | $63.10 | $158K | 30,246 |
| 2022-12-13 | Mueller Brian EVP, Chief Financial Officer | Sale | −2,500 | $107.50 | $269K | 27,746 |
| 2022-12-13 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion · Stock Option (Right to buy Common Stock) | −2,500 | 7,500 | ||
| 2022-12-13 | BIENAIME JEAN JACQUES Chief Executive Officer | Sale | −1,000 | $106.89 | $107K | 320,424 |
| 2022-12-02 | Mueller Brian EVP, Chief Financial Officer | Sale | −1,101 | $104.50 | $115K | 27,746 |
| 2022-12-02 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion | +2,139 | $67.81 | $145K | 29,885 |
| 2022-12-02 | Mueller Brian EVP, Chief Financial Officer | Sale | −2,139 | $104.50 | $224K | 27,746 |
| 2022-12-02 | Mueller Brian EVP, Chief Financial Officer | Exercise or conversion | +3,761 | $67.81 | $255K | 31,507 |
| 2022-12-02 | Mueller Brian EVP, Chief Financial Officer | Sale | −3,761 | $104.50 | $393K | 27,746 |
Page 19 of 23 · 450 trades